Immunovant Sciences
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (19)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Started: 5/27/2025
Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
Started: 11/6/2022
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
Started: 1/5/2023
Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
Started: 6/27/2022
Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
Started: 11/23/2022
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Started: 3/18/2025
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Started: 6/30/2025
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Started: 6/19/2025
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Started: 12/17/2024
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
Started: 1/26/2026
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
Started: 1/10/2025
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
Started: 2/19/2025
A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease
Started: 5/15/2023
An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Started: 8/28/2025
To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP
Started: 12/15/2022
A Study of RVT-1401 in Myasthenia Gravis (MG) Patients
Started: 5/21/2019
ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )
Started: 7/23/2019
To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA).
Started: 8/11/2020
Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)
Started: 4/22/2019